15 studies found for:    VCL
Show Display Options
Rank Status Study
1 Completed A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Genetic: VCL-IM01 (encoding IL-2) with Electroporation
2 Completed Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge
Condition: Cytomegalovirus Infection
Interventions: Biological: VCL CT02 pDNA vaccine;   Biological: Towne CMV vaccine
3 Completed Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
Condition: Cytomegalovirus Infection
Intervention: Biological: Towne CMV vaccine
4 Completed Pandemic Influenza Plasmid DNA Vaccines (Needle)
Condition: Influenza
Interventions: Biological: VCL-IPT1;   Biological: VCL-IPM1;   Biological: PBS
5 Completed Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)
Condition: Influenza
Interventions: Biological: VCL-IPM1;   Biological: VCL-IPT1;   Biological: PBS
6 Recruiting Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: VCL-HB01;   Biological: VCL-HM01;   Biological: PBS
7 Completed Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Conditions: Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome
Interventions: Biological: VCL-CB01;   Other: Phosphate-buffered Saline (PBS)
8 Withdrawn CS DNA MVA Trial in Mampong, Ghana
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: MVA-CSO Vaccine;   Biological: PfCSP DNA (VCL-2510) Vaccine
9 Completed The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique
Condition: Pediatric Hydrocephalus
Intervention:
10 Terminated Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Leuvectin
11 Terminated Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Leuvectin
12 Completed Phase II Trial of Allovectin-7® for Metastatic Melanoma
Conditions: Melanoma;   Metastatic Melanoma;   Malignant Melanoma;   Skin Cancer
Intervention: Genetic: Allovectin-7®
13 Completed Phase II Trial of Allovectin-7® for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Oral Cavity or Oropharynx;   Head and Neck Neoplasms;   Carcinoma of the Head and Neck
Intervention: Genetic: Allovectin-7®
14 Completed Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Intervention: Drug: allovectin-7
15 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine

Indicates status has not been verified in more than two years